Literature DB >> 23808615

The effects of acute treatment with paroxetine, amitriptyline, and placebo on the equilibrium function in healthy subjects: a double-blind crossover trial.

Seiko Miyata1, Akiko Noda, Kunihiro Iwamoto, Masahiro Takahashi, Yuki Hara, Jun Kojima, Tetsuya Iidaka, Norio Ozaki.   

Abstract

OBJECTIVE: Depression is common in old age, and is treatable with antidepressants. However, antidepressants use can increase the risk of falls. Thus, we assessed the effects of antidepressants on equilibrium function using posturography.
METHODS: This study recruited 10 healthy male volunteers (35.3 ± 3.7 years). In this double-blinded, three-way crossover trial, they received acute doses of 10 mg paroxetine, 25 mg amitriptyline, and placebo. They were administered posturography at baseline and 4-h postdosing.
RESULTS: At 4-h postdosing, amitriptyline significantly decreased the locus length per unit area (L/A) and increased the envelope area compared with those at baseline. Meanwhile, the total length and the locus length per time (L/T) at 4-h postdosing of amitriptyline did not show significant differences from those at baseline. After paroxetine treatment, there were no significant differences in total length, L/T, L/A, and the envelope area between baseline and 4-h postdosing.
CONCLUSION: An acute dose of amitriptyline significantly decreased L/A and increased the envelope area as markers of body sway. Evaluation of equilibrium function is important for preventing the potential risk of falls and body sway after taking antidepressants.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23808615     DOI: 10.3109/13651501.2013.813551

Source DB:  PubMed          Journal:  Int J Psychiatry Clin Pract        ISSN: 1365-1501            Impact factor:   1.812


  1 in total

1.  Unilateral cathodal transcranial direct current stimulation over the parietal area modulates postural control depending with eyes open and closed.

Authors:  Shinichiro Oka; Takuro Ikeda; Tsubasa Mitsutake; Katsuya Ogata; Yoshinobu Goto
Journal:  PLoS One       Date:  2022-09-22       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.